References
- Evans TC, Roberge RJ. Quincke's disease of the uvula. Am J Emerg Med. 1987;5:211–216.
- Alcoceba E, Gonzalez M, Gaig P, et al. Edema of the uvula: etiology, risk factors, diagnosis, and treatment. J Investig Allergol Clin Immunol. 2010;20:80–83.
- Zuberbier T, Aberer W, Asero R, et al. Endorsed by the following societies: AAAAI, AAD, AAIITO, ACAAI, AEDV, APAAACI, ASBAI, ASCIA, BAD, BSACI, CDA, CMICA, CSACI, DDG, DDS, DGAKI, DSA, DST, EAACI, EIAS, EDF, EMBRN, ESCD, GA2LEN, IAACI, IADVL, JDA, NVvA, MSAI, OGDV, PSA, RAACI, SBD, SFD, SGAI, €SGDV, SIAAIC, SIDeMaST, SPDV, TSD, UNBB, UNEV and WAO. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018;73:1393–1414.
- Crampsey DP, Little SA. Uvula angio-oedema: ENT form of Saturday night palsy. BMJ. 2007;335:318.
- Nussberger J, Cugno M, Cicardi M. Bradykinin-mediated angioedema. N Engl J Med. 2002;347:621–622.
- Cicardi M, Aberer W, Banerji A, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014;69:602–616.
- Temino VM, Peebles RS. The spectrum and treatment of angioedema. Am J Med. 2008;121:282–286.
- Magen E, Mishal J, Zeldin Y, et al. Clinical and laboratory features of antihistamine-resistant chronic idiopathic urticaria. Allergy Asthma Proc. 2011;32:460–466.
- Faisant C, Boccon-Gibod I, Mansard C, et al. Idiopathic histaminergic angioedema without wheals: a case series of 31 patients. Clin Exp Immunol. 2016;185:81–85.
- Zazzali JL, Kaplan A, Maurer M, et al. Angioedema in the omalizumab chronic idiopathic/spontaneous urticarial pivotal studies. Ann Allergy Asthma Immunol. 2016;117:370–377e1.
- Kaplan AP. Treatment of chronic spontaneous urticaria. Allergy Asthma Immunol Res. 2012;4:326–331.
- Buyukozturk S, Gelincik A, Demirturk M, et al. Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: a real life survey. J Dermatol. 2012;39:439–442.
- Sands MF, Blume JW, Schwartz SA. Successful treatment of 3 patients with recurrent idiopathic angioedema with omalizumab. J Allergy Clin Immunol. 2007;120:979–981.
- Azofra J, Díaz C, Antépara I, et al. Positive response to omalizumab in patients with acquired idiopathic nonhistaminergic angioedema. Ann Allergy Asthma Immunol. 2015;114:418–419.